NEW YORK, Jan. 16, 2021 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of ACM Research, Inc. (NASDAQ: ACMR) between March 6, 2019 and October 7, 2020, inclusive (the "Class Period"), of the important February 19, 2021 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for ACM investors under the federal securities laws.

To join the ACM class action, go to http://www.rosenlegal.com/cases-register-2013.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email This email address is being protected from spambots. You need JavaScript enabled to view it. or This email address is being protected from spambots. You need JavaScript enabled to view it. for information on the class action.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) ACM’S revenue and profits had been diverted to undisclosed related parties; (2) accordingly, ACM had materially overstated its revenues and profits; and (3) as a result, defendants’ statements about ACM’s business, operations, and prospects lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 19, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-register-2013.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at This email address is being protected from spambots. You need JavaScript enabled to view it. or This email address is being protected from spambots. You need JavaScript enabled to view it..

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. AN INVESTOR’S ABILITY TO SHARE IN ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT UPON SERVING AS LEAD PLAINTIFF.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm’s attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors. Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:
      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 40th Floor
      New York, NY 10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      This email address is being protected from spambots. You need JavaScript enabled to view it.
      This email address is being protected from spambots. You need JavaScript enabled to view it.
      This email address is being protected from spambots. You need JavaScript enabled to view it.
      www.rosenlegal.com

PETALING JAYA, Malaysia, Jan. 16, 2021 (GLOBE NEWSWIRE) -- Toga Limited (OTC: TOGL), unveiled “Yippi X,” the new version of its revolutionary flagship app Yippi, on January 5, 2021, at the inaugural ASEAN New Tech Conference (“ANTC”). The ANTC was held online this year and carried the theme “Together We Change the World”.

“Yippi X was developed by our team of experts to be the most powerful version of the Yippi app to date. It provides a more comprehensive user experience, as compared to Yippi’s 5th Generation, Yippi 5, released back in July 2019,” said Toga Limited’s Chief Executive Officer and founder, Mr. Michael Toh.

“Yippi X is a total upgrade in terms of its technical capabilities and is more refined compared to Yippi 5. What's interesting is that we have redefined Yippi in line with its tagline, ‘Let the World Know You’, focusing on users first, and bringing them closer in the virtual world through its newly enhanced social and messaging features,” said Toh.

Toh acknowledges that “2020 has been a challenging year for everyone. However, due to the diligence and perseverance of Toga’s employees and its executives, as well as the continuous support and commitment from its shareholders, Toga managed to weather the storm and emerge stronger than ever in its response to the pandemic crisis.”

“Toga has helped more than 30,000 content creators in 10 countries across the globe to grow and diversify their income streams. It is good to note that Toga is one of the few technology companies that has achieved rapid growth in business development during these trying times,” said Toh.

Other new and updated mobile applications were also unveiled at the ANTC, including:

• TogaGo 2.0, which is focused on becoming a one-stop travel solution. It offers an improved user-friendly design and an expanded range of useful functionalities. One of its key features ‘GO Cash’ allows users to enjoy a host of privileges when they purchase products and services on the platform. Users can redeem GO Cash points against future purchases and get discounts and exclusive deals.
• E.Booster 2.0, which is aimed at creating a healthier lifestyle for its users. E-Booster 2.0 uses the unique energy resonance technology called ‘Toga Resonance Technology (T-RT)’, to maintain good health and a positive attitude towards life. It has more than 40 products which can be found under five basic categories of use, namely for Focus, Stress Relief, Protection, Meditation and Energize, covering the most comprehensive health care.
• Red Box Karaoke’s Booking and Social Singing apps, which was developed through a partnership between Red Box and Toga. Red Box was looking into digitalization innovations to attain its vision of becoming South East Asia’s leader in the karaoke industry, and Toga came forward to provide them with IT infrastructure solutions, ranging from research and development to technology selection.
  

Article published: https://www.theedgemarkets.com/content/advertise/toga-looks-towards-the-future-with-new-apps-and-partnerships

Contact:

Alexander D. Henderson
TOGA LIMITED, 515 S. Flower Street, 18^th Floor, Los Angeles, CA 90071
(949) 333-1603
This email address is being protected from spambots. You need JavaScript enabled to view it.

Certain statements in this press release are forward-looking as defined in the Private Securities Litigation Reform Act of 1995. Any statements contained herein that are not statements of historical fact (including, but not limited to, statements to the effect that Toga Limited or its management (the “Company”) "anticipates," "plans," "estimates," "expects," or "believes," or the negative of these terms and other similar expressions) should be considered forward-looking statements, including, without limitation, statements regarding the Company's guidance, outlook, growth, opportunities and long-term strategy. These statements involve certain risks and uncertainties that may cause actual results to differ materially from expectations as of the date of this release. These risks and uncertainties include, without limitation, risks associated with the impact of the COVID-19 pandemic; the Company's ability to execute on its long-term strategy; the Company's ability to successfully compete in its intensely competitive industry; the Company's ability to manage its growth; the Company's ability to maintain or improve its operating margins; the Company's ability to identify and react to trends in consumer preferences; product supply disruptions; general economic conditions; accounting standard changes; and other factors as set forth from time to time in the Company's Securities and Exchange Commission filings, including, without limitation, the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. The Company intends these forward-looking statements to speak only as of the time of this Press Release and does not undertake to update or revise them as more information becomes available, except as required by law.

BOCA RATON, Fla., Jan. 15, 2021 (GLOBE NEWSWIRE) -- Saxena White P.A. has filed a securities fraud class action lawsuit in the United States District Court for the Northern District of California against Penumbra, Inc. (“Penumbra” or the “Company”) (NYSE: PEN) on behalf of all persons or entities who purchased or otherwise acquired Penumbra common stock between August 3, 2020 and December 15, 2020, inclusive (the “Class Period”).

If you purchased Penumbra common stock during the Class Period and wish to apply to be lead plaintiff, a motion on your behalf must be filed with the Court no later than March 16, 2021. You may contact David Kaplan (This email address is being protected from spambots. You need JavaScript enabled to view it.), an attorney and Director at Saxena White P.A., to discuss your rights regarding the appointment of lead plaintiff or your interest in the class action. You may also retain counsel of your choice and need not take any action at this time to be a class member.

Penumbra is a global healthcare company that develops, manufactures and sells innovative medical devices for patients suffering from stroke and other vascular and neurovascular diseases. Until recently, one of the Company’s flagship products was the “Jet 7 Xtra Flex,” an aspiration catheter designed to be inserted into an affected artery, navigated to a blood clot, and used to suck the clot out of the patient’s body. In mid-2020, concerns about the Jet 7 Xtra Flex’s safety began to emerge. Despite these concerns, Penumbra repeatedly assured investors during the Class Period that the Jet 7 Xtra Flex was “absolutely safe,” “exactly what we hoped it would be,” and “not a product that has any possibility of needing to be recalled.” The Company further assured investors that it was taking all necessary steps to protect patients.

As alleged in the Class Action Complaint, these statements and other statements that Defendants made during the Class Period were materially false and misleading in violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, and SEC Rule 10b-5. Specifically, the Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose material adverse facts about the Jet 7 Xtra Flex’s safety, as well as the Company’s business, operations, and prospects. Among other things, Defendants failed to disclose to investors: (1) that the Jet 7 Xtra Flex had known design defects that made it unsafe for its normal use; (2) that Penumbra did not adequately address the risk of Jet 7 Xtra Flex causing serious injury and deaths, which had in fact already occurred; (3) that the Jet 7 Xtra Flex was likely to be recalled due to its safety issues; and (4) as a result, Penumbra’s public statements as set forth above were materially false and misleading at all relevant times.

The truth emerged through a series of disclosures that caused Penumbra’s stock price to fall and investors to suffer substantial losses. On September 14, 2020, the Foundation for Financial Journalism, an independent non-profit news outlet, published an article raising serious issues about the Jet 7 Xtra Flex’s safety profile, citing twelve deaths reported to the FDA that occurred after a surgeon injected an iodine contrast dye into the Jet 7 Xtra Flex, and claiming that warnings against using the product with contrast dye and non-Penumbra products did little to address the Jet 7 Xtra Flex’s safety issues. In response, Penumbra’s stock price fell by nearly 3%, from $199.43 per share on September 13, 2020 to $193.66 per share on September 14, 2020, a decline of $5.77 per share.

On November 9, 2020, the securities research firm Quintessential Capital Management (“QCM”) released a presentation concerning Penumbra and the safety of the Jet 7 Xtra Flex. Titled “Penumbra and Its Killer Catheter,” QCM’s report detailed injuries and deaths resulting from product malfunctions, and accused Penumbra of a “seemingly blatant disregard for patients’ lives” and essentially “blaming doctors” for the devices’ design defects.

On November 23, 2020, an article was published in the Journal of NeuroInterventional Surgery presenting the cases of three patients who suffered as a result of Jet 7 Xtra Flex device malfunctions, including two fatalities. As this report became more widely circulated, it caused Penumbra stock to fall from $254.71 on November 23, 2020, to $224.12 on November 25, 2020, a decline of about 12%.

On December 8, 2020, QCM issued another report reiterating its prior assertions and disclosing additional facts about the Jet 7 Xtra Flex’s safety issues. In particular, QCM’s second report questioned the validity and independence of the scientific research supporting the Jet 7 Xtra Flex’s safety, and accusing the Company of using a fake author to publish studies regarding the purported safety and efficacy of its products. In response, Penumbra’s stock price declined by 9%, falling from $224.02 per share on December 7, 2020 to $204.07 per share on December 8, 2020, a decline of $19.95 per share.

Finally, on December 15, 2020, after the market closed, the Company issued a press release announcing that it was issuing an “urgent” and “voluntary” recall of the Jet 7 Xtra Flex because the catheter “may become susceptible to distal tip damage during use” which could lead to injury or death. In response, Penumbra’s stock price fell 7%, from $188.82 per share on December 15, 2020 to $174.98 per share on December 16, 2020, a decline of $13.84 per share.

You may obtain a copy of the Complaint and inquire about actively joining the class action at www.saxenawhite.com.

Saxena White P.A., with offices in Florida, New York, Delaware, and California, is a leading national law firm focused on prosecuting securities class actions and other complex litigation on behalf of injured investors. Currently serving as lead counsel in numerous securities fraud class actions nationwide, Saxena White has recovered billions of dollars on behalf of injured investors.

CONTACT INFORMATION
David Kaplan, Esq.
This email address is being protected from spambots. You need JavaScript enabled to view it.
Saxena White P.A.
12750 High Bluff Drive, Suite 475
San Diego, CA 92130
Tel: (858) 987-0860
Fax: (858) 369-0096
www.saxenawhite.com

Washington, D.C., Jan. 15, 2021 (GLOBE NEWSWIRE) --

USDA FSIS
USDA Food Safety and Inspection Service
(202) 720-9113
This email address is being protected from spambots. You need JavaScript enabled to view it.

NEW YORK, Jan. 15, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Zoom Video Communications, Inc. (NASDAQ: ZM) on behalf of long-term stockholders. Our investigation concerns whether the board of directors of Zoom have breached their fiduciary duties to the company.

Our investigation follows a securities class action complaint that was filed against Zoom on April 7, 2020.

The Complaint alleges that throughout the Class Period defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. Specifically, defendants made false and/or misleading statements and/or failed to disclose that: (i) Zoom had inadequate data privacy and security measures; (ii) contrary to Zoom’s assertions, the Company’s video communications service was not end-to-end encrypted; (iii) as a result of all the foregoing, users of Zoom’s communications services were at an increased risk of having their personal information accessed by unauthorized parties, including Facebook; (iv) usage of the Company’s video communications services was foreseeably likely to decline when the foregoing facts came to light; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

If you are a long-term stockholder of Zoom, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker, Melissa Fortunato, or Marion Passmore by email at This email address is being protected from spambots. You need JavaScript enabled to view it., or telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.

About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact Information:
Bragar Eagel & Squire, P.C.
Melissa Fortunato, Esq.
Marion Passmore, Esq.
(212) 355-4648
This email address is being protected from spambots. You need JavaScript enabled to view it.
www.bespc.com